This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. The post 4 ways to embed data-driven best practice in pharma HCP communications appeared first on. For more information, visit veeva.com/eu.
The pandemic has triggered a change in how pharmaceuticalcompanies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceuticalcompany engagement during the crisis. The answer was yes.
Using content metrics, companies can understand how their current content is received and engaged with, which will, in turn, helps clarify the most effective and efficient ways to connect and communicate with their audience in the future, resulting in increased speed to market and effective content engagement.
Preamble Why this WhitePaper? A whitepaper (sometimes called as whitepaper) is an information document issued by an organization to highlight the solution to a problem the functionality of a solution, good, or service. In this whitepaper, we will explore the key principles of GMaP in the pharmaceutical industry.
RSV researchers at major pharmaceuticalcompanies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceuticalcompanies are pushing to develop drugs and vaccines for RSV with these populations in mind.
Media coverage regarding the nomination has been largely focused on concerns expressed by some about Dr. Califf’s past work with pharmaceuticalcompanies in clinical research. It takes courage, fortitude that support the pursuit of clear goals that are clearly communicated to a myriad of stakeholders.
Pharmaceuticalcompanies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
He goes on to say that this might incentivize more pharmaceuticalcompanies to develop drugs that target the biology of aging. The incentive from the FDA’s perspective would be the possible larger effect size on multiple age-related diseases compared to that of drugs currently being developed,” he says.
GlobalData calculates these risk scores by evaluating several qualitative and quantitative factors to establish the quality of conditions and the level of stability of the market access environment encountered by pharmaceuticalcompanies in each country. Please check your email to download the Report.
In the 1990s, generic pharmaceuticalcompanies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. It was a money-saving strategy that was paying off until Covid-19 hit. Please check your email to download the Report.
Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceuticalcompanies of international origin within the country. by 2040 based on statistics from OECD. </p> By Tanner Pharma Group.
However, Amgen and other pharmaceuticalcompanies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. Impact on the industry Veal says that for a lot of pharmaceuticalcompanies there is no “big drive to think about optimizing treatment” post-licensing.
With its highly educated, English-speaking workforce and high-quality medical facilities system, Singapore has attracted leading pharmaceuticalcompanies to open their regional headquarters in the city-state, including Novo Nordisk (Bagsvaerd, Denmark) and GSK. Please check your email to download the Report.
This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceuticalcompanies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.
Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceuticalcompanies. In addition, packaging components are not entirely manufactured in a clean room environment, making them a potential source of exogenous contamination.
The CLR is a great option for pharmaceuticalcompanies performing steam sterilisation in the drying chamber. The CLR is temperature controlled to 160°C, enabling the highest accuracy and protection against condensation. But that isn’t the only demanding application in the freeze drying world.
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.
About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ) SZ) and Tigermed (300347.SZ Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Please check your email to download the Whitepaper.
This could evolve into pharmaceuticalcompanies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.
Shoring these up will be a prerequisite for ushering in the age of decentralised pharmaceuticals. Pharmaceuticalcompanies need real-time visibility and insights into their supply chains to ensure patients are getting the therapies they need when they need them. Please check your email to download the Report.
It is also essential to evaluate the reliability of the company supplying the ingredient: do they provide sufficient communication and documentation? Will they ensure you are notified about any change to the product? Is Benzalkonium Chloride a good choice? Please check your email to download the Whitepaper.
For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. The stakes are high when launching an orphan drug product, however. Please check your email to download the Case Study.
According to Baker Mackenzie , a law firm brand that specialises in a range of industries including healthcare and life sciences, IPOs allow pharmaceuticalcompanies to “access major global finance hubs and capital from a deep pool of investors around the world”. Please check your email to download the Report.
These single-use technologies allow pharmaceuticalcompanies to achieve continuous manufacturing, which significantly reduces the risk of cross-contamination without the need for extensive cleaning and disinfecting. Please check your email to download the Webinar.
Celnova Pharma is an Argentina-based pharmaceuticalcompany that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. The company currently has operations in Argentina, Colombia, Chile, Peru, and Uruguay. Please check your email to download the Report.
Shoring these up will be a prerequisite for ushering in the age of decentralised pharmaceuticals. Pharmaceuticalcompanies need real-time visibility and insights into their supply chains to ensure patients are getting the therapies they need when they need them. Please check your email to download the Report.
As pharmaceuticalcompanies launch their products across European countries, the joint procedure is intended to reduce the duplication of submissions with different evidence requirements and procedural times required at a country level, and thus streamline workflows and reduce administrative burden.
Explaining the rise of HPAPIs, Bruno Villa, CEO, MEDELPHARM believes the trend is a consequence of the increasing pressure on pharmaceuticalcompanies to develop drugs with improved efficiency and efficacy. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology.
This guidance has driven many pharmaceuticalcompanies to revaluate their approach to CCIT. According to Lukas Engel, market manager pharma CCIT at Pfeiffer Vacuum, companies are increasingly looking to perform high throughput testing with sophisticated, deterministic methods.
Starting research early and using the findings to inform R&D decisions gives pharmaceuticalcompanies the best chance of success when they come to scale the many market access obstacles presented by Europe. Overall, it is never too soon to begin market access activities, but it can easily be too late.
Most drugs used here are prescribed off-label, and experts say pharmaceuticalcompanies remain hesitant to conduct clinical trials studying gender-affirming care. Barry DeCoster, PhD, an associate professor of bioethics at the University of Michigan, describes gender affirming care as “safe and effective” for most patients.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content